Discover, Develop & Selectively Deliver Highly Stable & Potent RNAi Therapeutics for Targeted & Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders & Beyond
As Novartis' landmark $12 billion acquisition of Avidity Biosciences and GSK's strategic $85 million partnership for an RNA-based COPD treatment signal unprecedented confidence in the modality, the focus now sharpens on overcoming its final frontier: delivery beyond the liver. This challenge is the central bottleneck to unlocking a broader therapeutic revolution, fueling a new wave of innovation from startups like Aerska, which secured $21 million to pioneer RNA interference (RNAi) for brain diseases.
Returning as the industry's premier dedicated forum, the 7th RNAi-Based Therapeutics Summit is the only event uniting the entire RNA interference ecosystem to translate the next wave of siRNA and microRNA drugs from bench to bedside. This year's conversation goes beyond the liver, focusing on the novel strategies turning extra-hepatic delivery into a clinical reality, from next-generation LNPs and conjugates to emerging platforms targeting the lungs, CNS, and skeletal muscle.
Join 80+ senior decision-makers from AbbVie, Alnylam, Judo Bio, Ceria Therapeutics and more to gain the data-focused insights and high-value connections needed to overcome stability challenges, de-risk clinical translation, and position your pipeline at the forefront of the next therapeutic revolution.
RNAi's Latest News:
Explore the Full Event Guide
- 25+ expert speakers from pioneering biotechs and large pharma, including Sanegene Bio, AbbVie, Judo Bio, and more, sharing exclusive data and case studies.
- Actionable insights to conquer extrahepatic delivery for CNS, muscle, and cardiac tissues with novel strategies like aptamers, bispecifics, and exosomes.
- Dedicated deep-dives on the hottest applications: from obesity and metabolic disease to neurology, oncology, and more.
- Critical regulatory and CMC strategies to overcome complex synthesis, scale-up, and IND-enabling hurdles for late-stage clinical success.
Expert RNAi Speakers Include:
Official Partners
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.